...
首页> 外文期刊>Industrial and organizational psychology >Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma
【24h】

Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma

机译:肝脏T / NK细胞淋巴瘤的T /天然杀伤剂(NK)细胞中的Epstein-BARR病毒肝炎重新激活

获取原文
获取原文并翻译 | 示例
           

摘要

Diagnosis of Epstein-Barr virus (EBV)-associated hepatitis, chronic active EBV infection, and EBV-associated lymphoproliferative diseases, is always challenging due to the overlapping symptoms and lack of diagnostic criteria. We report such a case of a 40-year-old man with unremarkable past medical history. He presented with fever of unknown origin for 1 month with jaundice for 2 days. Physical exams were unremarkable with body temperature at 98.6 degrees F. His liver function tests were elevated with alanine transaminase (ALT) 559 U/L, aspartate transaminase (AST) 892 U/L, alkaline phosphatase 319 U/L and total bilirubin 4.4 mg/dL. Computed tomography of his chest, abdomen and pelvis did not show lymphadenopathy or hepatosplenomegaly. A liver biopsy showed moderately acute hepatitis with hemophagocytosis, positive Epstein-Barr virus encoding RNA (EBER) in situ hybridization in CD3 and CD4-positive T cells and CD56-positive natural killer (NK) cells. CD20 was negative. The pathology diagnosis was consistent with reactivation of EBV hepatitis but NK-cell lymphoma needs to be excluded. Steatohepatitis with mild activity was present. His blood EBV DNA was 846,000 copies/mL and continued to increase to 2,000,000 copies/mL. Flow cytometric analysis of his bone marrow revealed an increased NK-cell activity but no T/NK-cell lymphoma was identified. Initial treatment with rituxan, etoposide and/or ruxolitinib/acyclovir failed or only had limited effect. However, subsequent valganciclovir greatly improved his conditions. In his 3 months follow-up, the patient was doing well with almost normal liver function tests except mildly elevated ALT (95 U/L) that was due to mild steatohepatitis. EBV DNA PCR was 2,009 copies/mL. To the best of our knowledge, this is the first documented case with reactivation of EBV hepatitis mimicking NK-cell lymphoma in the English literature. With appropriate anti-EBV viral treatments, the patient eventually became asymptomatic and was able to return to his routine life.
机译:Epstein-Barr病毒(EBV)的诊断 - 分类肝炎,慢性活性EBV感染和EBV相关的淋巴抑制性疾病,由于症状重叠和缺乏诊断标准,始终挑战。我们报告了一个40岁男性的一个未解重的过去的病史。他呈现出未知起源的发烧,持续1个月与黄疸2天。体温对体温的体温在98.6°F。他的肝功能试验用丙氨酸转氨酶(ALT)559 U / L,天冬氨酸转氨酶(AST)892 U / L,碱性磷酸酶319 U / L和总胆红素4.4mg / DL。胸部,腹部和骨盆的计算机断层扫描没有显示淋巴结病或肝脾肿大。肝脏活组织检查显示血小阴症中度急性肝炎,用渗透性症,阳性Epstein-BARR病毒编码RNA(EBER)在CD3和CD4阳性T细胞和CD56阳性天然杀伤(NK)细胞中。 CD20是阴性的。病理学诊断与EBV肝炎的再活化一致,但需要排除NK细胞淋巴瘤。存在轻度活动的脱脂性肝炎。他的血液EBV DNA为846,000份/ ml,继续增加到2,000,000份/ ml。其骨髓的流式细胞术分析显示出越升高的NK细胞活性,但没有鉴定出T / NK细胞淋巴瘤。用柠檬酸,依托磷脂和/或劳洛替尼/ acyclovir失败或仅效果有限处理。然而,随后的Valganciclovir大大改善了他的条件。在他3个月的随访中,除了脱脂性肝炎的温和升高(95 U / L)外,患者几乎正常的肝功能试验表现良好。 EBV DNA PCR为2,009份/ mL。据我们所知,这是第一个有权重新激活EBV肝炎模仿英国文学中的NK细胞淋巴瘤的文件。通过适当的抗EBV病毒治疗,患者最终变得无症状,能够恢复他的日常生活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号